Detalles de la búsqueda
1.
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury.
Spinal Cord
; 2024 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38898145
2.
Clinical features of coronavirus disease 2019 (COVID-19) in a cohort of patients with disability due to spinal cord injury.
Spinal Cord Ser Cases
; 6(1): 39, 2020 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32404896
3.
Why Does COVID-19 Affect Patients with Spinal Cord Injury Milder? A Case-Control Study: Results from Two Observational Cohorts.
J Pers Med
; 10(4)2020 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33096722
Resultados
1 -
3
de 3
1
Próxima >
>>